School of Medicine
Showing 101-110 of 120 Results
-
Simon H. Stertzer, MD, FACC,FAHA,FACP
Professor of Medicine (Cardiovascular) at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsCoronary Angioplasty; Intramyocardial Stem cell delivery
-
David A. Stevens
Professor of Medicine, Emeritus
Current Research and Scholarly InterestsImmunology and chemotherapy of human fungal diseases, particularly coccidioidomycosis (Valley Fever) in California and aspergillosis, and the parasitic disease, trypanosomiasis.
-
Frank E. Stockdale
Maureen Lyles D'Ambrogio Professor in the School of Medicine, Emeritus
Current Research and Scholarly InterestsLaboratory and clinical research in breast cancer ; Normal and abornal differentiation and growth
-
Sarah Streett
Clinical Professor, Medicine - Gastroenterology & Hepatology
BioDr. Sarah Streett is a Clinical Professor of Medicine, the Director of Inflammatory Bowel Disease Education at Stanford, and she is passionate about taking care of people with IBD. She is a national expert in treating complex IBD and initiated a multi-disciplinary approach to care with colorectal surgery, pediatrics, and nutrition. In 2018 she received the Champion of Hope Award from the Crohn’s and Colitis Foundation and serves on their National Scientific Advisory Committee. Her interests focus on fertility and pregnancy in people with IBD, developing precision approaches to IBD therapy, and the role that the microbiome and diet play in its pathogenesis. She is a primary investigator of the Stanford IBD Registry and has research projects focused on optimizing clinical outcomes in IBD, the role of the microbiota and diet in IBD and pregnancy, and applying new technologies to individualizing therapy for IBD. She is also the primary investigator on multiple industry-sponsored IBD trials.
Teaching is a top priority for Dr. Streett who feels that mentoring fellows in the development of their careers is a privilege. She has held many national leadership roles in the American Gastroenterological Association, where she has been Chair of the Practice Management and Economics Committee, and currently serves on the Government Affairs Committee. She also an appointed member of the Gastrointestinal Drug Advisory Committee at the FDA. She has represented the interests of gastroenterologists and their patients on Capitol Hill numerous times. Dr. Streett believes strongly in a collaborative approach to give patients personalized care based on the latest therapies for the treatment of IBD and is committed to mentoring the next generation of experts in the field. -
Eric Strong
Clinical Associate Professor, Medicine
Current Research and Scholarly InterestsPhysical diagnosis, ECG interpretation, generative AI, and clinical reasoning.
-
Ashley Styczynski
Adjunct Clinical Assistant Professor, Medicine - Infectious Diseases
BioAshley Styczynski, MD, MPH, is an Adjunct Clinical Assistant Professor in the Division of Infectious Diseases & Geographic Medicine and Global Health Faculty Fellow, and a Medical Officer in the International Infection and Control Program at the Centers for Disease Control and Prevention (CDC). Dr. Styczynski's research interests are in infectious disease epidemiology, global health, emerging infections, and antimicrobial resistance. She holds an MPH from Johns Hopkins Bloomberg School of Public Health and an MD from University of Illinois at Chicago. Prior to coming to Stanford for her infectious disease fellowship, she spent two years as an Epidemic Intelligence Service (EIS) Officer at the CDC. During her time as an EIS officer, Dr. Styczynski conducted outbreak investigations on Zika virus, vaccinia virus, and rabies. She is currently conducting research on antimicrobial resistance and interventions to reduce nosocomial infections within low-resource healthcare facilities.
-
Aruna Subramanian
Clinical Professor, Medicine - Infectious Diseases
Current Research and Scholarly InterestsMy research and scholarly interests have focused on tailoring antimicrobial prophylaxis in specific highly immunocompromised hosts depending on their specific infectious disease risks. I am interested in developing diagnostic algorithms and treatment protocols that will improve the quality of care in transplant and oncology patients.
I also have an interest in training ID fellows in this very specialized area of patient care. To that end, we have started a new ICHS ID fellowship with a specialized curriculum and are developing supplemental educational materials to enhance this training, which can be implemented at other academic training centers.
